The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 3.79 is strong.
JMI Hospital Requisite Manufacturing has a Altman Z-Score of 3.84, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:JHRML vs ISRG, BDX, MDLN: Altman Z-Score Comparison
For the Medical Instruments & Supplies subindustry, JMI Hospital Requisite Manufacturing's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMI Hospital Requisite Manufacturing Altman Z-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMI Hospital Requisite Manufacturing's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where JMI Hospital Requisite Manufacturing's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
JMI Hospital Requisite Manufacturing (DHA:JHRML) has a Altman Z-Score of 3.84 as of Jul. 09, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on JMI Hospital Requisite Manufacturing and its competitors. This is 24% below median its historical median of 5.08. Over the past decade, JMI Hospital Requisite Manufacturing's Altman Z-Score has ranged from 2.28 to 8.49. According to the industry distribution chart, JMI Hospital Requisite Manufacturing ranks #342 out of 808 companies in the Medical Devices & Instruments industry, placing it in the top 42.3%.
Is JMI Hospital Requisite Manufacturing's Altman Z-Score too high?
JMI Hospital Requisite Manufacturing's current Altman Z-Score of 3.84 is 24% below median its 10-year median of 5.08. Over the past 10 years, this metric has ranged from a low of 2.28 to a high of 8.49. The Medical Devices & Instruments industry median Altman Z-Score is 2.99. JMI Hospital Requisite Manufacturing's value of 3.84 is 28.6% above this industry median. Based on the distribution chart, JMI Hospital Requisite Manufacturing ranks #342 out of 808 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, JMI Hospital Requisite Manufacturing has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JMI Hospital Requisite Manufacturing's Altman Z-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMI Hospital Requisite Manufacturing ranks #342 out of 808 companies for Altman Z-Score. This puts JMI Hospital Requisite Manufacturing in the upper half of its industry. The industry median Altman Z-Score is 2.99. JMI Hospital Requisite Manufacturing's value of 3.84 is 28.6% above this benchmark. Historically, JMI Hospital Requisite Manufacturing's own Altman Z-Score has ranged from 2.28 to 8.49 over the past decade. While the company's 10-year median is 5.08 vs. the industry median of 2.99, JMI Hospital Requisite Manufacturing has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 2.99, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMI Hospital Requisite Manufacturing's current Altman Z-Score of 3.84 is 28.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on JMI Hospital Requisite Manufacturing and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMI Hospital Requisite Manufacturing's current Altman Z-Score is 3.84, which is 24% below median its own 10-year median of 5.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Hospital Requisite Manufacturing stock overvalued right now?
Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing (DHA:JHRML) is currently considered Fairly Valued. The stock's GF Value™ is BDT50.92, compared to a current price of BDT52.60 — trading 3.3% above its estimated fair value. The current Altman Z-Score is 3.84, which is 24% below median its 10-year median of 5.08 and 28.6% above the Medical Devices & Instruments industry median of 2.99. JMI Hospital Requisite Manufacturing's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For JMI Hospital Requisite Manufacturing (DHA:JHRML), the current Altman Z-Score is 3.84 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMI Hospital Requisite Manufacturing (DHA:JHRML) Overvalued in 2026?
Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing stock appears to be overvalued.
The current stock price of BDT52.60 is trading 3.3% above its estimated GF Value™ of BDT50.92.
GuruFocus considers JMI Hospital Requisite Manufacturing to be Fairly Valued.
Key valuation signals for DHA:JHRML:
Altman Z-Score: 3.84 (24% below median its 10-year median of 5.08)
GF Value™: BDT50.92 vs. price of BDT52.60 (3.3% above fair value)
Industry Position: 28.6% above the Medical Devices & Instruments median (#342 of 808)
No single metric tells the full story. See the DHA:JHRML stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMI Hospital Requisite Manufacturing Business Description
JMI Hospital Requisite Manufacturing Ltd is engaged in the production of medical devices and components. The company produces health & hospicare products. The products of the company include Surgical Sutures, Surgical Gloves, IV Cannula, Bulk Needles, Blister Film, Infusion Set Components, Disposable Scalpels, Nasal Oxygen Cannulas, Blood Transfusion Sets, Urine Drainage Bags, Scalp Vein Sets, and others.
67GF Score
Get the complete analysis for DHA:JHRML
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:JHRML has been successfully added to your 
